Integrated BioPharma Q1 revenue down 16% to $12.8M; net income falls to $0.5M

INTEGRATED BIOPHARMA INC

2021-Q1 EPS reported $0.02 revenue$12,751,000

Revenue $12.8M vs $15.2M YoY, a decrease of 16.0%.
Operating income $0.6M vs $1.5M; net income $0.5M ($0.02 basic EPS) vs $1.0M ($0.04 basic EPS).
Diluted EPS $0.02 vs $0.03 in the prior-year quarter.
Two largest customers in Contract Manufacturing Segment accounted for ~91% of revenue, consistent with YoY.
Co-CEOs cite pandemic-related safety stock and consumer demand in prior year as cause for revenue decline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.